{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:06:39Z","timestamp":1788336399204,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00259-020-04846-3","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T21:02:48Z","timestamp":1588971768000},"page":"123-133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [68Ga]Ga-PSMA-11-PET\/CT in the evaluation of prostate cancer patients"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5588-3363","authenticated-orcid":false,"given":"Christian","family":"Uprimny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Bayerschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Stephan","family":"Kroiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Nilica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Svirydenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Decristoforo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpaolo","family":"di Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"von Guggenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Horninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Johanna","family":"Virgolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"4846_CR1","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00259-017-3711-7","volume":"44","author":"A Afshar-Oromieh","year":"2017","unstructured":"Afshar-Oromieh A, Holland-Letz T, Giesel FL, Kratochwil C, Mier W, Haufe S, et al. Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET\/CT in patients with recurrent prostate cancer: evaluation in 1007 patients. Eur J Nucl Med Mol Imaging. 2017;44:1258\u201368. https:\/\/doi.org\/10.1007\/s00259-017-3711-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4846_CR2","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00259-018-4067-3","volume":"45","author":"P Caroli","year":"2018","unstructured":"Caroli P, Sandler I, Matteucci F, De Giorgi U, Uccelli L, Celli M, et al. 68Ga-PSMA PET\/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients. Eur J Nucl Med Mol Imaging. 2018;45:2035\u201344. https:\/\/doi.org\/10.1007\/s00259-018-4067-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4846_CR3","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","volume":"5","author":"WP Fendler","year":"2019","unstructured":"Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, et al. Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial. JAMA Oncol. 2019;5:856\u201363. https:\/\/doi.org\/10.1001\/jamaoncol.2019.0096.","journal-title":"JAMA Oncol"},{"key":"4846_CR4","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00259-017-3882-2","volume":"45","author":"I Virgolini","year":"2018","unstructured":"Virgolini I, Decristoforo C, Haug A, Fanti S, Uprimny C. Current status of theranostics in prostate cancer. Eur J Nucl Med Mol Imaging. 2018;45:471\u201395. https:\/\/doi.org\/10.1007\/s00259-017-3882-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4846_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10354-017-0569-z","volume":"169","author":"C Uprimny","year":"2019","unstructured":"Uprimny C. Ga-PSMA-11 PET\/CT: the rising star of nuclear medicine in prostate cancer imaging? Wien Med Wochenschr. 2019;169:3\u201311. https:\/\/doi.org\/10.1007\/s10354-017-0569-z.","journal-title":"Wien Med Wochenschr"},{"key":"4846_CR6","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","volume":"44","author":"WP Fendler","year":"2017","unstructured":"Fendler WP, Eiber M, Beheshti M, Bomanji J, Ceci F, Cho S, et al. Ga-PSMA PET\/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2017;44:1014\u201324. https:\/\/doi.org\/10.1007\/s00259-017-3670-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4846_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","volume":"40","author":"A Afshar-Oromieh","year":"2013","unstructured":"Afshar-Oromieh A, Malcher A, Eder M, Eisenhut M, Linhart HG, Hadaschik BA, et al. PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur J Nucl Med Mol Imaging. 2013;40:486\u201395. https:\/\/doi.org\/10.1007\/s00259-012-2298-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4846_CR8","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1007\/s00259-017-3725-1","volume":"44","author":"S Fanti","year":"2017","unstructured":"Fanti S, Minozzi S, Morigi JJ, Giesel F, Ceci F, Uprimny C, et al. Development of standardized image interpretation for 68Ga-PSMA PET\/CT to detect prostate cancer recurrent lesions. Eur J Nucl Med Mol Imaging. 2017;44:1622\u201335. https:\/\/doi.org\/10.1007\/s00259-017-3725-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4846_CR9","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00259-013-2660-z","volume":"41","author":"A Afshar-Oromieh","year":"2014","unstructured":"Afshar-Oromieh A, Haberkorn U, Schlemmer HP, Fenchel M, Eder M, Eisenhut M, et al. Comparison of PET\/CT and PET\/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience. Eur J Nucl Med Mol Imaging. 2014;41:887\u201397. https:\/\/doi.org\/10.1007\/s00259-013-2660-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4846_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1148\/rg.2018170108","volume":"38","author":"MS Hofman","year":"2018","unstructured":"Hofman MS, Hicks RJ, Maurer T, Eiber M. Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls. Radiographics. 2018;38:200\u201317. https:\/\/doi.org\/10.1148\/rg.2018170108.","journal-title":"Radiographics."},{"key":"4846_CR11","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s00259-016-3594-z","volume":"44","author":"MT Freitag","year":"2017","unstructured":"Freitag MT, Radtke JP, Afshar-Oromieh A, Roethke MC, Hadaschik BA, Gleave M, et al. Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET\/CT and PET\/MRI: comparison with mpMRI integrated in simultaneous PET\/MRI. Eur J Nucl Med Mol Imaging. 2017;44:776\u201387. https:\/\/doi.org\/10.1007\/s00259-016-3594-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4846_CR12","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.2967\/jnumed.117.204669","volume":"59","author":"FL Giesel","year":"2018","unstructured":"Giesel FL, Will L, Lawal I, Lengana T, Kratochwil C, Vorster M, et al. Intraindividual comparison of 68Ga-PSMA-11-PET\/CT and multiparametric MR for imaging of primary prostate cancer. J Nucl Med. 2018;59:1076\u201380. https:\/\/doi.org\/10.2967\/jnumed.117.204669.","journal-title":"J Nucl Med"},{"key":"4846_CR13","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00259-017-3743-z","volume":"44","author":"C Uprimny","year":"2017","unstructured":"Uprimny C, Kroiss AS, Fritz J, Decristoforo C, Kendler D, von Guggenberg E, et al. Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence. Eur J Nucl Med Mol Imaging. 2017;44:1647\u201355. https:\/\/doi.org\/10.1007\/s00259-017-3743-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4846_CR14","doi-asserted-by":"publisher","first-page":"e0183329","DOI":"10.1371\/journal.pone.0183329","volume":"12","author":"T Heu\u00dfer","year":"2017","unstructured":"Heu\u00dfer T, Mann P, Rank CM, Sch\u00e4fer M, Dimitrakopoulou-Strauss A, Schlemmer HP, et al. Investigation of the halo-artifact in 68Ga-PSMA-11-PET\/MRI. PLoS One. 2017;12:e0183329. https:\/\/doi.org\/10.1371\/journal.pone.0183329.","journal-title":"PLoS One"},{"key":"4846_CR15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2214\/AJR.17.19356","volume":"211","author":"KA Wangerin","year":"2018","unstructured":"Wangerin KA, Baratto L, Khalighi MM, Hope TA, Gulaka PK, Deller TW, et al. Clinical evaluation of 68Ga-PSMA-11 and 68Ga-RM2 PET images reconstructed with an improved scatter correction algorithm. AJR Am J Roentgenol. 2018;211:655\u201360. https:\/\/doi.org\/10.2214\/AJR.17.19356.","journal-title":"AJR Am J Roentgenol"},{"key":"4846_CR16","doi-asserted-by":"publisher","first-page":"153601211881174","DOI":"10.1177\/1536012118811741","volume":"17","author":"C Lawhn-Heath","year":"2018","unstructured":"Lawhn-Heath C, Flavell RR, Korenchan DE, Deller T, Lake S, Carroll PR, et al. Scatter artifact with Ga-68-PSMA-11 PET: severity reduced with furosemide diuresis and improved scatter correction. Mol Imaging. 2018;17:1536012118811741. https:\/\/doi.org\/10.1177\/1536012118811741.","journal-title":"Mol Imaging"},{"key":"4846_CR17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s11307-016-0945-x","volume":"18","author":"V Prasad","year":"2016","unstructured":"Prasad V, Steffen IG, Diederichs G, Makowski MR, Wust P, Brenner W. Biodistribution of [(68)Ga]PSMA-HBED-CC in patients with prostate cancer: characterization of uptake in normal organs and tumour lesions. Mol Imaging Biol. 2016;18:428\u201336. https:\/\/doi.org\/10.1007\/s11307-016-0945-x.","journal-title":"Mol Imaging Biol"},{"key":"4846_CR18","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1007\/s00259-017-3718-0","volume":"44","author":"A Afshar-Oromieh","year":"2017","unstructured":"Afshar-Oromieh A, Wolf M, Haberkorn U, Kachelrie\u00df M, Gnirs R, Kopka K, et al. Effects of arm truncation on the appearance of the halo artifact in. Eur J Nucl Med Mol Imaging. 2017;44:1636\u201346. https:\/\/doi.org\/10.1007\/s00259-017-3718-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4846_CR19","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/1754-9485.12625","volume":"61","author":"N Fennessy","year":"2017","unstructured":"Fennessy N, Lee J, Shin J, Ho B, Ali SA, Paschkewitz R, et al. Frusemide aids diagnostic interpretation of 68Ga-PSMA positron emission tomography\/CT in men with prostate cancer. J Med Imaging Radiat Oncol. 2017;61:739\u201344. https:\/\/doi.org\/10.1111\/1754-9485.12625.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"4846_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s00259-019-04548-5","volume":"47","author":"F Haupt","year":"2020","unstructured":"Haupt F, Dijkstra L, Alberts I, Sachpekidis C, Fech V, Boxler S, et al. Ga-PSMA-11 PET\/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocol. Eur J Nucl Med Mol Imaging. 2020;47:624\u201331. https:\/\/doi.org\/10.1007\/s00259-019-04548-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4846_CR21","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2967\/jnumed.116.183483","volume":"58","author":"A Afshar-Oromieh","year":"2017","unstructured":"Afshar-Oromieh A, Sattler LP, Mier W, Hadaschik BA, Debus J, Holland-Letz T, et al. The clinical impact of additional late PET\/CT imaging with 68Ga-PSMA-11 (HBED-CC) in the diagnosis of prostate cancer. J Nucl Med. 2017;58:750\u20135. https:\/\/doi.org\/10.2967\/jnumed.116.183483.","journal-title":"J Nucl Med"},{"key":"4846_CR22","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1007\/s00330-016-4308-4","volume":"26","author":"T Derlin","year":"2016","unstructured":"Derlin T, Weiberg D, von Klot C, Wester HJ, Henkenberens C, Ross TL, et al. Ga-PSMA I&T PET\/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging. Eur Radiol. 2016;26:4345\u201353. https:\/\/doi.org\/10.1007\/s00330-016-4308-4.","journal-title":"Eur Radiol"},{"key":"4846_CR23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4103\/ijnm.IJNM_32_18","volume":"33","author":"G Perveen","year":"2018","unstructured":"Perveen G, Arora G, Damle NA, Prabhu M, Arora S, Tripathi M, et al. Can early dynamic positron emission tomography\/computed tomography obviate the need for postdiuresis image in 68Ga-PSMA-HBED-CC scan for evaluation of prostate adenocarcinoma? Indian J Nucl Med. 2018;33:202\u20138. https:\/\/doi.org\/10.4103\/ijnm.IJNM_32_18.","journal-title":"Indian J Nucl Med"},{"key":"4846_CR24","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00259-017-3631-6","volume":"44","author":"C Uprimny","year":"2017","unstructured":"Uprimny C, Kroiss AS, Decristoforo C, Fritz J, von Guggenberg E, Kendler D, et al. Ga-PSMA-11 PET\/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour. Eur J Nucl Med Mol Imaging. 2017;44:941\u20139. https:\/\/doi.org\/10.1007\/s00259-017-3631-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4846_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/01621459.1952.10483441","volume":"47","author":"WH Kruskal","year":"1952","unstructured":"Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc. 1952;47:583\u2013621. https:\/\/doi.org\/10.1080\/01621459.1952.10483441.","journal-title":"J Am Stat Assoc"},{"key":"4846_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/00401706.1964.10490181","volume":"6","author":"OJ Dunn","year":"1964","unstructured":"Dunn OJ. Multiple comparisons using rank sums. Technometrics. 1964;6:241\u201352. https:\/\/doi.org\/10.1080\/00401706.1964.10490181.","journal-title":"Technometrics."},{"key":"4846_CR27","first-page":"65","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65\u201370.","journal-title":"Scand J Stat"},{"key":"4846_CR28","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2307\/2529511","volume":"32","author":"CJ Scheirer","year":"1976","unstructured":"Scheirer CJ, Ray WS, Hare N. The analysis of ranked data derived from completely randomized factorial designs. Biometrics. 1976;32:429\u201334. https:\/\/doi.org\/10.2307\/2529511.","journal-title":"Biometrics."},{"key":"4846_CR29","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2018","unstructured":"R Core Team. R: A language and environment for statistical computing. Austria: Vienna: R Foundation of Statistical Computing; 2018. https:\/\/www.r-project.org\/"},{"key":"4846_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/RLI.0b013e31828234d0","volume":"48","author":"FC Gaertner","year":"2013","unstructured":"Gaertner FC, Beer AJ, Souvatzoglou M, Eiber M, F\u00fcrst S, Ziegler SI, et al. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography\/magnetic resonance in comparison with positron emission tomography\/computed tomography in patients with neuroendocrine tumors. Investig Radiol. 2013;48:263\u201372. https:\/\/doi.org\/10.1097\/RLI.0b013e31828234d0.","journal-title":"Investig Radiol"},{"key":"4846_CR31","first-page":"81","volume":"3","author":"DA Silver","year":"1997","unstructured":"Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res. 1997;3:81\u20135.","journal-title":"Clin Cancer Res"},{"key":"4846_CR32","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1001\/jama.284.23.3043","volume":"284","author":"Association WM","year":"2000","unstructured":"Association WM. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2000;284:3043\u20135.","journal-title":"JAMA."}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-04846-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-020-04846-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-04846-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T23:33:49Z","timestamp":1620430429000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-020-04846-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4846"],"URL":"https:\/\/doi.org\/10.1007\/s00259-020-04846-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"assertion":[{"value":"27 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional and national research committee and with the principles of the 1964 Declaration of Helsinki and its subsequent amendments []. In accordance with our local regulations, ethical approval was waived, as the study was conducted retrospectively from data obtained for clinical purposes. Written informed consent was obtained from all patients prior to the exam, and the retrospective study was conducted according to institutional guidelines and is in compliance with the specific requirements of our country.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}